technetium and tp 3654
technetium has been researched along with tp 3654 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chakder, S; Pallela, VR; Rattan, S; Thakur, ML | 1 |
| Ahdoot, R; Diggles, L; Kalinowski, EA; Le Pham, H; Marcus, CS; Minami, C; Pallela, V; Saeed, S; Thakur, ML | 1 |
| Diggles, L; Li, H; Marcus, CS; Minami, C; Pallela, V; Patti, R; Pham, HL; Rao, PS; Reddy, K; Sharma, S; Thakur, ML | 1 |
| Acton, P; Alavi, A; Aruva, MR; Gariepy, J; Prasad, S; Rattan, S; Thakur, ML; Wickstrom, E | 1 |
Other Studies
4 other study(ies) available for technetium and tp 3654
| Article | Year |
|---|---|
99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies.
Topics: Animals; Binding, Competitive; Colorectal Neoplasms; Humans; In Vitro Techniques; Iodine Radioisotopes; Mice; Mice, Nude; Muscle Contraction; Muscle, Smooth; Neoplasm Transplantation; Oligopeptides; Opossums; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Receptors, Vasoactive Intestinal Peptide; Technetium; Transplantation, Heterologous; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1999 |
99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans.
Topics: Adult; Feasibility Studies; Female; Humans; Isotope Labeling; Male; Middle Aged; Neoplasms; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Time Factors; Vasoactive Intestinal Peptide | 2000 |
99mTc labeled VIP analog: evaluation for imaging colorectal cancer.
Topics: Colorectal Neoplasms; Humans; Indium Radioisotopes; Kidney; Octreotide; Oligopeptides; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Technetium; Tissue Distribution; Vasoactive Intestinal Peptide | 2001 |
PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Copper Radioisotopes; Dose-Response Relationship, Drug; Drug Stability; Female; Isometric Contraction; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Weight; Muscle, Smooth; Oligopeptides; Opossums; Organ Specificity; Peptides; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; Reproducibility of Results; Sensitivity and Specificity; Technetium; Tissue Distribution; Tomography, Emission-Computed; Vasoactive Intestinal Peptide | 2004 |